查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423400

2024-2032 年按產品、應用、最終用戶和地區分類的白蛋白市場報告

Albumin Market Report by Product, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2023年全球白蛋白市場規模達61億美元。展望未來， IMARC Group預計到2032年市場規模將達到98億美元，2024-2032年複合年成長率（CAGR）為5.4%。治療低血容的手術中廣泛採用產品、改善醫療基礎設施（尤其是在發展中地區）以及私人和公共投資湧入醫療保健是推動市場的一些主要因素。

白蛋白是主要由肝臟產生的蛋白質，在多種生理功能中發揮至關重要的作用。它是人體血漿中最豐富的蛋白質，透過維持滲透壓來調節血液量。白蛋白也作為荷爾蒙、脂肪酸和藥物等物質的載體分子，幫助它們在體內運輸。白蛋白的一個關鍵功能是幫助防止液體從血管中滲漏，從而確保必需的液體保留在循環系統內。血液中白蛋白的異常水平可以表示各種健康狀況。低水平可能表示肝臟或腎臟疾病、營養不良或慢性疾病，而水平升高通常不太常見，可能表示脫水或嚴重感染。因此，白蛋白水平的測量通常包含在血液測試中，作為常規醫學評估的一部分。

外科手術數量的增加主要推動了全球市場。白蛋白通常在手術中用於治療低血容積，即血漿容量減少的情況。隨著全球人口持續老化以及手術技術的不斷進步，進行的手術數量不斷增加。這一趨勢與白蛋白需求的上升直接相關，從而推動市場成長。促進市場成長的另一個重要因素是白蛋白產業向新興市場的擴張。發展中國家提供了一個尚未開發的市場，醫療保健支出不斷增加，醫療保健基礎設施不斷改善。隨著這些國家醫療保健系統的進步，對包括白蛋白在內的高品質醫療用品的需求不斷增加。此外，人們越來越意識到早期診斷和治療需要白蛋白的疾病的重要性，這是推動市場的另一個因素。此外，私人和公共投資的湧入醫療保健領域正在創造積極的市場前景。

白蛋白市場趨勢/促進因素：

慢性病發生率上升

白蛋白產業最重要的市場促進因素之一是肝硬化、腎臟疾病和糖尿病等慢性疾病發生率的上升。這些情況通常會導致白蛋白水平異常，需要定期監測並可能進行補充。此外，這些慢性病的盛行率不斷上升與人口老化、不良飲食習慣以及缺乏運動和高壓力等生活方式因素有關。同時，不斷成長的患者群體需要增加用於診斷和治療目的的白蛋白產品的供應。治療這些疾病對白蛋白的需求不斷增加，從而推動了該行業的成長。醫院和診所正在加強對基於白蛋白的測試和治療的依賴，從而增加需求並推動市場成長。

生物技術和藥物研究進展

生物技術和藥物研究的技術進步也被證明是白蛋白產業的主要動力。這些進步促進了大規模分離、純化和生產白蛋白的方法的改進，使其更容易獲得且更具成本效益。此外，重組 DNA 技術的創新技術為白蛋白應用開闢了新途徑，包括將其用作標靶治療的藥物遞送劑。此外，研究進展為白蛋白在傷口癒合和組織再生等新應用的使用鋪平了道路。對研發活動的持續投資顯示白蛋白產業前景光明，有助於其擴張。

監管支持和批准

政府法規和指南在推動白蛋白市場方面發揮著至關重要的作用。監管機構為白蛋白產品的安全生產、品質控制和分銷提供指南。同時，此類標準化的存在不僅可以建立消費者的信任，還可以鼓勵製藥公司投資高品質的產品。及時批准新的基於白蛋白的產品或療法可以大大加速市場滲透，從而成為該行業的驅動力。此外，這些指南的全球統一確保了供應鏈的精簡和高效，從而促進新的和創新的白蛋白產品更快地上市。

本報告回答的關鍵問題

  • 2023年全球白蛋白市場規模？
  • 2024-2032年全球白蛋白市場的預期成長率是多少？
  • 推動全球白蛋白市場的關鍵因素是什麼？
  • COVID-19 對全球白蛋白市場有何影響？
  • 基於該產品的全球白蛋白市場的詳細情形如何？
  • 根據應用，全球白蛋白市場的詳細情形如何？
  • 基於最終用戶的全球白蛋白市場的詳細情形如何？
  • 全球白蛋白市場的重點區域有哪些？
  • 全球白蛋白市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球白蛋白市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 人血清白蛋白
    • 市場走向
    • 市場預測
  • 牛血清白蛋白
    • 市場走向
    • 市場預測
  • 重組白蛋白
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 療法
    • 市場走向
    • 市場預測
  • 藥物製劑和疫苗
    • 市場走向
    • 市場預測
  • 媒體的組成部分
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 研究機構
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Albumedix Ltd
    • Biotest AG
    • Celgene Corporation (Bristol-Myers Squibb Company)
    • CSL Limited
    • Grifols SA
    • HiMedia Laboratories
    • Medxbio Pte Ltd
    • Merck KGaA
    • Octapharma AG
    • Takeda Pharmaceutical Company Limited
    • Thermo Fisher Scientific Inc.
    • Ventria Bioscience Inc.
Product Code: SR112024A4493

Abstract

The global albumin market size reached US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The widespread product adoption in the operations to treat hypovolemia, the improving healthcare infrastructure, especially across developing regions, and the influx of both private and public investment in healthcare are some of the major factors propelling the market.

Albumin is a protein produced primarily by the liver and plays a vital role in various physiological functions. It is the most abundant protein in human blood plasma and serves to regulate blood volume by maintaining the osmotic pressure. Albumin also acts as a carrier molecule for substances such as hormones, fatty acids, and medications, aiding in their transport throughout the body. A key function of albumin is to help prevent fluid leakage from blood vessels, thus ensuring that essential fluids remain within the circulatory system. Abnormal levels of albumin in the blood can be indicative of various health conditions. Low levels may point to liver or kidney disorders, malnutrition, or chronic illness, while elevated levels are generally less common and could be indicative of dehydration or severe infection. Hence, the measurement of albumin levels is often included in blood tests as part of routine medical assessments.

The increasing number of surgical procedures majorly drives the global market. Albumin is commonly used in operations to treat hypovolemia, a condition where there is a decrease in the volume of blood plasma. As the global population continues to age and as surgical techniques continue to advance, the number of surgeries being performed is increasing. This trend directly correlates with an uptick in the demand for albumin, thereby driving market growth. Another significant factor contributing to market growth is the expansion of the albumin industry into emerging markets. Developing countries present an untapped market with increasing healthcare spending and improving healthcare infrastructure. As healthcare systems in these countries advance, the demand for high-quality medical supplies, including albumin, rises. In addition, the accelerating awareness about the importance of early diagnosis and treatment of conditions that require albumin is another factor driving the market. Moreover, the influx of both private and public investment in healthcare is creating a positive market outlook.

Albumin Market Trends/Drivers:

Rising Incidence of Chronic Diseases

One of the most significant market drivers for the albumin industry is the rising incidence of chronic diseases such as liver cirrhosis, kidney disorders, and diabetes. These conditions often result in abnormal albumin levels, necessitating regular monitoring and possible supplementation. In addition, the escalating prevalence of these chronic diseases is linked to an aging population, poor dietary habits, and lifestyle factors like lack of exercise and high stress levels. In confluence with this, the growing patient pool demands an increasing supply of albumin products for both diagnostic and therapeutic purposes. The escalating need for albumin in treating these diseases is thereby propelling growth in the industry. Hospitals and clinics are intensifying their reliance on albumin-based tests and treatments, thereby increasing demand and driving market growth.

Advances in Biotechnology and Pharmaceutical Research

Technological advancements in biotechnology and pharmaceutical research have also proven to be a major driver for the albumin industry. These advances have facilitated improved methods of isolating, purifying, and producing albumin on a large scale, thereby making it more accessible and cost-effective. Additionally, innovative techniques in recombinant DNA technology have opened new avenues for albumin applications, including its use as a drug delivery agent for targeted therapies. Additionally, progress in research has paved the way for albumin's use in novel applications such as wound healing and tissue regeneration. The ongoing investments in research and development activities indicate a promising trajectory for the albumin industry, contributing to its expansion.

Regulatory Support and Approvals

Governmental regulations and guidelines play a crucial role in driving the albumin market. Regulatory bodies provide guidelines for the safe production, quality control, and distribution of albumin products. In confluence with this, the presence of such standardizations not only builds consumer trust but also encourages pharmaceutical companies to invest in high-quality products. Timely approvals for new albumin-based products or therapies can substantially accelerate market penetration, thereby acting as a driver for the industry. Moreover, the global harmonization of these guidelines ensures a streamlined and efficient supply chain, facilitating faster time-to-market for new and innovative albumin-based products.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global albumin market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Human Serum Albumin

Bovine Serum Albumin

Recombinant Albumin

Human serum albumin dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes human serum albumin, bovine serum albumin, and recombinant albumin. According to the report, human serum albumin represented the largest segment.

The market for human serum albumin products within the albumin industry is experiencing robust growth, propelled by multiple market drivers. A key influencer is the escalating prevalence of chronic liver and kidney diseases that necessitate regular monitoring and treatment of albumin levels. The rising number of surgical procedures, where human serum albumin is used to manage fluid balance, further fuels demand. Advances in biotechnological methods have made it easier to produce and purify human serum albumin, thereby making the product more cost-effective and accessible. This has led to its increased utilization in a range of medical and non-medical applications, such as drug formulation and vaccine stabilization. Additionally, the industry benefits from the regulatory support of agencies like the FDA and EMA, which ensures the quality and safety of these products, building consumer trust. Investment in healthcare from both public and private sectors also aids in market expansion, supporting research and development activities for innovative applications of human serum albumin. These factors collectively serve to drive the market for human serum albumin products.

Breakup by Application:

Therapeutics

Drug Formulation and Vaccine

Component of Media

Others

Therapeutics holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. These include therapeutics, drug formulation and vaccine, component of media, and others. According to the report, therapeutics accounted for the largest market share.

The therapeutics application segment in the albumin industry is witnessing significant growth, driven by multiple converging factors. Foremost among these is the increasing prevalence of chronic conditions like liver disease, kidney disorders, and diabetes, which necessitate the use of albumin-based treatments to regulate blood volume and protein levels. The rising number of surgical procedures, especially in an aging global population, also contributes to elevated demand for albumin as it is commonly used to manage fluid balance during surgeries. Advances in biotechnological research have led to the development of specialized albumin formulations optimized for drug delivery systems, thereby expanding its therapeutic applications. Regulatory bodies like the FDA and EMA have facilitated market growth by setting stringent quality control measures, thereby ensuring the efficacy and safety of albumin products used in therapeutics. Investments from private and public sectors in healthcare infrastructure and research also provide a conducive environment for the expansion of albumin's therapeutic applications. These driving factors combine to propel the market growth of the therapeutics application in the albumin industry.

Breakup by End User:

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Research Institutes

Hospitals and clinics dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes. According to the report, hospitals and clinics represented the largest segment.

The hospital and clinics segment is a major end-user in the albumin industry, and its market growth is fueled by several influential drivers. First and foremost, the rise in the incidence of chronic diseases like liver and kidney disorders requires consistent monitoring and treatment, often involving albumin-based products. This creates a steady demand for albumin in hospital settings for both diagnostic and therapeutic applications. Furthermore, the increasing number of surgical procedures that utilize albumin for fluid management further escalates demand within hospitals and clinics. Advances in healthcare infrastructure, supported by both public and private investment, have led to an uptick in the adoption of albumin products, as these settings aim for better patient outcomes and quality of care. Regulatory support, in the form of guidelines from bodies like the FDA and EMA, assures the quality of albumin products, thereby building trust and facilitating their usage in hospital settings. Collectively, these factors make hospitals and clinics a pivotal end-user segment, driving demand and, consequently, market growth for the albumin industry.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest albumin market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America exhibited the largest segment.

The albumin industry in North America is experiencing significant growth, driven by a variety of factors that create a strong demand for albumin products. One major driver is the high prevalence of chronic conditions like liver diseases, kidney disorders, and diabetes in the region, necessitating frequent monitoring and intervention involving albumin. Additionally, North America has a well-developed healthcare infrastructure with a substantial number of surgical procedures taking place annually, thereby increasing the usage of albumin for surgical and critical care. Technological advancements in biopharmaceuticals, supported by considerable R&D investment, have also contributed to diversifying albumin applications, further driving the market. Regulatory support from agencies such as the FDA assures product quality and safety, enhancing consumer trust. Furthermore, public and private investments in healthcare have been strong, resulting in more hospitals, clinics, and healthcare facilities that use albumin products. These factors, along with a generally aging population that requires more healthcare services, collectively serve to propel the market growth for the albumin industry in North America.

Competitive Landscape:

The global market is experiencing significant growth due to the new albumin formulations and applications. Innovation in this area can lead to more effective and versatile albumin products, opening new markets and therapeutic avenues. Along with this, companies are expanding into emerging markets where there is rising healthcare spending and an increasing patient pool. This diversification helps mitigate risks associated with dependence on mature markets. In addition, the escalating strategic partnerships with other healthcare companies, research institutions, and even governmental bodies help in sharing knowledge, costs, and distribution networks. Therefore, this is significantly supporting the market. With regulatory bodies emphasizing the safety and efficacy of medical products, companies in the albumin market are focusing on quality control to adhere to these guidelines, further impacting the market. In addition, brands are adopting advanced logistics and inventory management systems to ensure timely delivery, which is acting as another growth-inducing factor. Furthermore, product differentiation by offering albumin products that serve specific niches within healthcare is contributing to the market.

The market report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Albumedix Ltd.

Biotest AG

Celgene Corporation (Bristol-Myers Squibb Company)

CSL Limited

Grifols SA

HiMedia Laboratories

Medxbio Pte Ltd.

Merck KGaA

Octapharma AG

Takeda Pharmaceutical Company Limited

Thermo Fisher Scientific Inc.

Ventria Bioscience Inc.

Recent Developments:

In July 2023, Grifols SA finished enrolling participants in its Phase III PRECIOSA clinical study using long-term Albutein (albumin-human injectable) treatment to prolong life in patients with decompensated cirrhosis.

In June 2023, Albumedix Ltd announced the extension of its current partnership with Valneva SE, a specialized vaccination business devoted to the prevention of infectious illnesses with important unmet medical needs.

In October 2022, Biotest AG announced the signing of a Memorandum of Understanding with Biotest AG for the production of plasma derivatives under a private label by Alpha Pharma for the KSA market.

Key Questions Answered in This Report

  • 1. What was the size of the global albumin market in 2023?
  • 2. What is the expected growth rate of the global albumin market during 2024-2032?
  • 3. What are the key factors driving the global albumin market?
  • 4. What has been the impact of COVID-19 on the global albumin market?
  • 5. What is the breakup of the global albumin market based on the product?
  • 6. What is the breakup of the global albumin market based on the application?
  • 7. What is the breakup of the global albumin market based on end user?
  • 8. What are the key regions in the global albumin market?
  • 9. Who are the key players/companies in the global albumin market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Albumin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Human Serum Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bovine Serum Albumin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Recombinant Albumin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Formulation and Vaccine
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Component of Media
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Albumedix Ltd
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Biotest AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Celgene Corporation (Bristol-Myers Squibb Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 CSL Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Grifols SA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 HiMedia Laboratories
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medxbio Pte Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Octapharma AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Ventria Bioscience Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Albumin Market: Major Drivers and Challenges
  • Figure 2: Global: Albumin Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Albumin Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Albumin Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Albumin Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Albumin Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Albumin Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Albumin (Human Serum Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Albumin (Human Serum Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Albumin (Bovine Serum Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Albumin (Bovine Serum Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Albumin (Recombinant Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Albumin (Recombinant Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Albumin (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Albumin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Albumin (Drug Formulation and Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Albumin (Drug Formulation and Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Albumin (Component of Media) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Albumin (Component of Media) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Albumin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Albumin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Albumin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Albumin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Albumin (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Albumin (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Albumin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Albumin Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Albumin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Albumin Industry: SWOT Analysis
  • Figure 78: Global: Albumin Industry: Value Chain Analysis
  • Figure 79: Global: Albumin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Albumin Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Albumin Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Albumin Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Albumin Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Albumin Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Albumin Market: Competitive Structure
  • Table 7: Global: Albumin Market: Key Players